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ABSTRACT 
Herein, we investigated the use of multimodal Raman and infrared (IR) spectroscopic microscopy for the elucidation of 
drug uptake and subsequent cellular responses. Firstly, we compared different methods for the analysis of the combined 
data. Secondly, we evaluated whether the combined analysis provided enough benefits to justify the fusion of the data. 
A459 cells inoculated with doxorubicin (DOX) at different times were fixed and analysed using each technique. Raman 
spectroscopy provided high sensitivity to DOX and enabled an accurate estimation of the drug uptake at each time point, 
whereas IR provided a better insight into the resultant changes in the biochemical composition of the cell. In terms of 
benefits of data fusion, 2D correlation analysis allowed the study of the relationship between IR and Raman variables, 
whereas the joint analysis of IR and Raman enabled the correlation of the different variables to be monitored over time. 
In summary, the complementary nature of IR and Raman makes the combination of these vibrational techniques an 
appealing tool to follow drug kinetics and cellular response. 
 




1. Introduction  
A clear understanding of drug modes and mechanism of action is essential for drug development and 
determination of clinical safety on both cellular and molecular levels.  For that matter, it is important to recognise the 
pattern of biochemical interactions which occurs in a cell under a pharmacological effect, from the assimilation of the 
drug by the cell to subsequent changes in the metabolic pathways and phenotypes produced. [1,2] 
The increase of restrictions in regulatory requirements in the EU and US (EU Directive-2010/63/EU and US 
Public Law 106-545, 2010, 106th Congress) has promoted the use of high throughput in-vitro investigations of modes 
and mechanisms of action. So far, the number of methodologies for identification of targets of drugs and their modes of 
action is still limited, however.[3,4] Omics technologies provide a wide range of approaches including lipidomic, 
proteomic and metabolomic techniques which enable the detection of several cellular biomolecules and a comprehensive 
analysis of the metabolic pathways altered by the drug. [5] However, in general they are time-consuming, need complex 
sample preparation and may destroy the sample. This makes it difficult to adapt these techniques as high-throughput 
methods to screen the mode and mechanism of action of the thousands of drug candidates developed yearly.  
Raman and Infrared (IR) spectroscopies are rapid, label-free and non-destructive methods which provide molecular 
information about a biochemical composition of a sample. These techniques, when combined  with  imaging microscopic 
systems, are used to study the distribution of  chemical substances in cells and tissues.[6,7] Raman microspectrocopy has 
been demonstrated to be capable of  monitoring sub-cellular drug accumulation and distribution of doxorubicin (DOX) 
in lung cancer cell lines and to identify the mechanism of the DOX action and cellular resistance.[8][9] With a spatial 
resolution similar to that of confocal laser scanning fluorescence microscopy [10,11], confocal Raman microspectroscopy 
indicated an initial accumulation and saturation of the drug in the nucleoli (~6 hrs), followed by nucleus of the cells 
(~12 hrs), before it began to accumulate in the cytoplasm (>24 hrs)[10,11] . 2D Correlation[12], as well as Multivariate 
Curve Resolution-Alternating Least Squares analysis  [9]  indicated a simultaneous evolution of spectral features 
associated with RNA in the nucleolus and DNA in the nucleus of the cells, associating the spectral signatures with the 
chemical binding, and therefore mechanism of action of the drug. Employing the median cytotoxic dose (IC50), as 
determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay, differences 
in the long term cellular responses  [11] of different cell lines were associated with cell recovery and anti-apoptotic 
mechanisms [13].  
On the other hand, IR has been successfully employed to follow molecular changes induced by chemotherapy 
drugs.[14] Similar to Raman microspectroscopy, the combination of IR spectroscopy and principal component analysis 
(PCA) [15] or partial least squares (PLS) [16]  has been proposed to distinguish the mode of action displayed by 
chemotherapeutics  such as tamoxifen, toremifene, imatinib, and DOX.  
Both, IR and Raman spectra provide information about the vibrational modes of molecules. However, they differ 
significantly in the mechanism of excitation from the ground state to the excited state and thus molecules can show very 
different activity for Raman and IR spectroscopy.[17] In IR, polar bonds from asymmetric molecules show strong bands, 
whereas symmetric and highly conjugated molecules are very active in Raman. In addition, Raman associated 
phenomena such as resonance or pre-resonance makes this technique particularly sensitive to molecular groups with 
electronic transitions close to the laser wavelength, generally in the visible and near IR range (e.g. chromophores).  
These differences make the techniques complementary in the investigation of complex matrices such as biological 
samples. For example, haemoglobin within red blood cells has been widely studied by both techniques. While the IR 
spectra is clearly dominated by the amide bands of the protein backbone,[18] the Raman spectrum is completely different, 
showing bands related to the heme group.[19]  In this regard, cells and tissues are composed of a wide variety of Raman 
and IR active molecules and the complementarity of the techniques can be exploited to obtain a more comprehensive 
analysis. For example, some (conjugated) drugs are very strong Raman scatterers and therefore easily tracked by Raman. 
DNA/RNA conjugated bases also show relatively strong Raman signals, but proteins show relatively stronger in IR. 
Furthermore, subcellular resolution is more readily accessible with Raman microscopy, whereas IR is more readily 
applicable to cell population studies. [20] 
Indeed, there is not a single technique or analytical configuration which can provide information of all the 
biomolecules from a clinical sample. The combination of different techniques which cover specific parts of the 
phenotype (e.g. proteome, lipidome and metabolome) is gaining popularity, allowing capture of a wider range of 
biomarkers and thus a more representative picture of the molecules involved.[21] The price to pay is the considerably 
increased complexity of the data analysis. The multimodal study of a biological process implies the simultaneous 
analysis of responses from different origins, which demands new ways to analyse data considering the relationship 
between the information and biomarkers addressed by the different modalities. In recent years, data fusion methods 
have been developed to study correlations between variables obtained using different spectroscopic methods,[22] as well 
as to draw comprehensive conclusions from extended datasets.[23] 
In the case of vibrational techniques, IR or Raman spectra are already intrinsically complex, being composed by 
multiple overlapping bands representing the concentration of the multitude of complex molecules within a sample. 
Hence, the combination of Raman and IR variables becomes a challenge. Different methods have been applied to 
integrate data from IR, Raman and other metabolic techniques, including PCA [24,25], 2D correlation analysis [26,27], MCR-
ALS [28] and joint individual variation analysis [29]. In the context of a drug uptake study, the analysis becomes even 
more complex when the incubation time variable is introduced in the system. In order to describe the drug kinetics as 
well as the responses of the cell expressed in the IR and Raman spectra, the correlations among the different variables 
should be studied across the duration of drug uptake by, and response of the cell.  
The aim of this academic exercise was to evaluate the simultaneous use of IR and Raman spectroscopy to study 
drug uptake and cellular response. To achieve this aim, we probed human lung carcinoma cells inoculated with DOX at 
different timepoints by means of near infrared Raman and High Definition (HD) Fourier Transform (FT)IR 
microspectroscopy. The study addressed (i) which methods are the most suitable for the analysis of the combined data 
and (ii) whether the joint analysis provided extra information in comparison with the individual analysis of both 
techniques and (iii) the usefulness of incorporating IR data considering that Raman is a well-established technique for 
the analysis. 
2. Methods 
2.1 Cell Culture 
Adenocarcinomic human alveolar basal epithelial A549 cells were cultured as in [11], using DMEM-F12 with 10% 
fetal bovine serum (FBS) at 37 °C in a humidified atmosphere containing 5% CO2. "Cells were subcultured regularly 
(2-3 days) in order to maintain a confluency of ~60% ".. Some aliquots of cells were seeded on CaF2 windows (~1 × 
104 /window) from Crystan Ltd (Dorset, UK) and incubated for 24 h. The medium was then removed, and samples were 
rinsed three times with PBS.  Then the cells were incubated with DOX at the median inhibitory concentration (IC50), 
adjusted to the cell number, for different time periods (0.5, 1, 2, 4, 7, 10, 20 and 48 h)  [11] incubation. The IC50 
cytotoxicity concentration used (0.55 µM) was previously determined using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT) assay (24 hours of incubation time).[11] The cells were then washed three times with sterile 
PBS before they were fixed in formalin (4%, 15 min). Prior to the analysis, samples were rinsed with ultrapure water. 
2.2 FT IR spectroscopic imaging  
Cells deposited on CaF2 windows were measured by FTIR microscopy using a  Agilent 670-IR FTIR spectrometer 
and a 620-IR microscope (Santa Clara, California) equipped with focal plane array (FPA) detector cooled with liquid 
nitrogen. The detector consists of matrix of 16 384 pixels, arranged in a 128 × 128 grid format. IR images were collected 
in transmission mode. High Definition (HD) FTIR spectroscopic imaging used a ×15 Cassegrain objective and 
condenser optics with NA of 0.62 and a projected FPA pixel size of 1.1 μm × 1.1 μm giving a measured area of 141 μm 
× 141 μm. A high magnification accessory was use giving a total IR system magnification of 36× with a spatial resolution 
of 3.0 μm at 2500 cm−1. All FTIR spectra were recorded by co-adding of 128 scans and in the range of 3800 to 900 cm−1 
with a spectral resolution of 4 cm−1. For each sample two images were obtained, covering 3-4 cells each. The pixels 
within a cell, covering both cytoplasm and nucleus, were manually selected and averaged to create a dataset containing 
5-8 spectra per cell for each timepoint.  
2.3 Raman 
Raman analysis was performed after the FTIR analysis in order to avoid any problems related to laser damage. 
Raman spectra were obtained using a Jobin Yvon LabRAM HR 800 spectrometer from Horiba (Kagawa, Japan) 
equipped with a Peltier cooled 16-bit CCD, 300 lines/mm grating and 100 μm confocal hole and a 785 nm, 300 mW 
diode laser as source (100% of laser power), resulting in ~70mW on the sample[11,13]. Spectra were acquired directly in 
dry conditions, using a ×100 objective (LCPlanN, Olympus) in the 400 cm−1- 1800 cm−1 range. For each cell, the average 
of 3 spectra obtained during 30s was computed. Spectra were randomly obtained from the cell region covering both 
nuclei and nucleoli. The final data set comprised spectra of 20-30 cells for each time point.  
2.4 Data Analysis 
Data preprocessing and analysis was performed using Matlab from Mathworks (NAtik, USA). Spectral pre-
processing, PCA and orthogonal partial least squares regression (oPLSR) were performed employing functions of the 
PLS-Toolbox library from Eigenvector Research Inc (Mason, USA). The synchronous spectrum was calculated using 
the function fft2dcorrelation from the MIDAS software[30]. MCR-ALS was obtained using the MCR-ALS GUI 
toolbox.[31] The scripts detailing the data analysis as well as the data are available in the Zenodo repository 
(10.5281/zenodo.3784974). Raman spectra were baselined using the “Weighted least squares” method from PLS-
toolbox (3-degree polynomial), normalised using the amide I band (1600-1700 cm-1) and smoothed using the Savitzky-
Golay algorithm, using a 9 points window. IR spectra were baselined using a  first order degree polynomial fitted on the 
1790-1780 and 950- 920 cm-1 regions, smoothed (Savitzky-Golay algorithm, 7 points window) and normalised with the 
“Standard Normal Variate” method. 
3. Results 
3.1 Monitoring drug uptake using Raman spectroscopy 
Figure 1a depicts the average (n=30) Raman spectra from cells fixed at different incubation times. The spectra 
show typical bands from cells, including protein bands corresponding to Amide I (~1655 cm-1) and Amide III vibrations 
(~1242 cm-1) [32], and lipid bands, such as the C-H deformation found at ~1441 cm-1[33], In addition, the band found at 
~785 cm-1  can be assigned to cytosine and thymine, while  that found at 816 cm-1 is assigned to the O–P–O stretching 
of RNA [8]. As the incubation time increases, several additional bands start to emerge. These correspond to vibrational 
modes of DOX, such as the C-C-O (~436 cm-1) and C-O (~457 cm-1) vibrations,[34] which are clearly spectrally isolated 
from the cell bands. Figure 1c shows the spectrum of a standard of pure DOX in aqueous solution, which indicates the 
presence of additional DOX bands, which overlap the cell features, notably the bands found at ~1212 and ~1245 cm-1, 
related to C-O-H and C-O groups, respectively.[8]  
The integrated value of the bands found in the range 430-482 cm-1 was used to follow the uptake of DOX by the 
cell as a function of incubation time (See Figure 1b). Values initially increased sharply, before reaching a plateau at ~ 
7-10 hours, indicating saturation of DOX inside the nucleus. This observation is in good agreement with previous 
studies[8], which indicated that the accumulation in the nucleolus and nucleus of the cells began to saturate at times of 
~6 and ~12 hours, respectively.”. It has to be noted that, in the current study, measurements over both nucleolus and 
nucleolus were integrated, which could explain the fact that the saturation time is in the middle of the interval previously 
reported for each subnuclear region measured independently. Furthermore, the large standard deviation found in this 
study was presumably caused by the lack of synchronization of the cells.  
PCA was performed to investigate multivariant trends in the data. The score values of the first two Principal 
Components, PC1 and PC2, showed spectral variations which were not correlated with time (See SM1). In contrast, the 
scores of the third PC showed a similar trend to that of the integrated DOX band (See Figure 1d). Moreover, the spectral 
loading of PC3 (See Figure 1c) shows identical features to the DOX standard, indicating that PC3 captured, to some 
extent, the variance associated with the introduction of the drug. Other minor peaks can be also observed, including the 
negative band found at 815 cm-1, which could indicate of the intercalation of the drug and nucleic acids [8,35]. DNA bands  
Negative bands in the 1250-1400 cm-1 region can be also observed.  
oPLSR was employed to regress the Raman spectra against incubation time, in order to acquire information about 
the contribution of each band to the kinetic process, but showed some limitations related to the fact that the relationship 
between the time and the DOX concentration was not linear. This can be observed in the poor correlation between the 
cross-validated (CV) predicted and actual time values (See Figure 1f) plot. This behaviour has been previously discussed 
with simulated data[9] and evidences the problems of using a linear model in a time dependent data unless the kinetic 
process is separated in linear trams. Nevertheless, the Root mean square error of cross validation  (RMSECV) error 
obtained (10.39 h) using 4 latent variables (LV) was deemed significant by a permutation test (p<0.005)[36], showing 
some correlation between the incubation time and the Raman spectra. Considering this value and that the correlation 
was observed in an unsupervised manner, spectral makers were investigated in the oPLSR model. The importance and 
direction of each variable in the model was studied using the selectivity ratio, a measure of the usefulness of each 
variable,  and the component loading of the oPLSR[37], respectively. Figure 1e shows the average Raman spectra as a 
scatter plot, in which the size of each variable is proportional to the selectivity ratio and the colour corresponds to the 
loading of the first LV, which accounts for the variation correlated with the variable to predict. The bands found at 436, 
461 and 1212 cm-1 showed both a high selectivity ratio and a high and positive loading value, indicating that the model 
used these bands to predict the time evolution. Furthermore, bands in the PC 1 loading showed similar shape than the 
DOX standard, suggesting that the intercalation of DOX with DNA did not perturb considerably the chemical 
environment of the drug. 
Raman spectroscopy is a well stablished technique for the evaluation of the drug uptake and cellular responses. In 
this study, Raman data showed similar patterns to those found in previous studies, demonstrating that multivariate 
analysis of Raman data provides useful information about the kinetics of DOX uptake by and initial interactions within 
the cells. The following section describes an analogous analysis using IR data in order to investigate changes in the 
chemical composition associated with the drug uptake. 
 
3.2 Evolution of the IR spectrum with the incubation time. 
Figure 2a depicts the average IR spectra of whole cells fixed after different incubation times, in which typical 
features of biological samples can be seen. Spectra are dominated by protein amide II (~1540 cm-1) and I (~1650 cm-1) 
bands [38,39], as well as phosphate stretching bands from nucleic acids (~1241 and ~1074 cm-1)[40]. The amide I could also 
contain contributions from the set of broad DNA and RNA bands between 1 ~1600 and 1720 cm-1[40], the latter being 
more clearly visible in Figure 2b. Lipid bands corresponding to the stretching mode of the ester C=O group and the 
bending mode of CH2 can be found at ~1740 and ~1455 cm-1,[41,42] respectively. In addition, the stretching band of the 
COO- group of fatty acids and amino acid side chains can be observed at ~1400 cm-1. [41] Furthermore, the 3050-2800 
cm-1 region presents bands associated with the stretching vibrations bands of C-H, corresponding to proteins, 
carbohydrates and lipids. [41] In particular, sharp bands found at ~2850 and ~2929 cm-1 correspond to the symmetric and 
asymmetric stretching of CH2 and are in general associated with the presence of alkyl chains of lipids. 
In comparison with the Raman analysis, no change of spectral profile as a function of incubation time is 
immediately obvious, on visual inspection. Similarly, PCA did not show any PC associated with the drug uptake, all the 
score values of the PCs being poorly correlated in any linear or non-linear fashion with the incubation time (See First 
3PCs in SM2). This observation indicated that, either the incubation time does not alter the spectra (i.e. changes on the 
biochemical composition are below the limit of detection of IR) or the variability associated is not a main source of 
spectral variation and was captured by a combination of different PCs. In theory, supervised methods such as oPLSR 
could deal with the latter, the main drawbacks being potential problems of overfitting and other pitfalls, which could 
lead to overoptimistic results if internal validation (e.g. CV) is used. Results of the oPLSR modelling using 4 LV of the 
incubation time are depicted in Figure 2b and 2c. The actual versus CV-predicted incubation time plot showed a similarly 
poor correlation observed for the Raman data, with a RMSECV value of 8.1 h. Although the permutation test computed 
acceptable significance values (p <0.02) for the RMSECV, considering that oPLSR was used to model a non-linear 
relationship, as well as the lack of any evidence of spectral changes associated with the incubation time found by the 
PCA, it is unrealistic to extract biochemical information from the model. 
As a highly polarisable, conjugated molecule, DOX is a strong Raman scatterer, but in comparison, a relatively 
weak IR absorber, and thus it is not unexpected that its spectral features are more strongly evident in the Raman spectral 
profile of the cell, whereas it is “invisible” in the IR spectrum. Nevertheless, the Raman signals from the previous 
experiment could assist in extracting biochemical information from the IR spectrum. The integration values of the DOX 
bands in the 430-480 cm-1 range are a good indicator of the uptake of the drug by the nucleus, so this value can be used 
as the output variable in oPLSR model to correlate IR variables with the presence and action of the drug in the cell. The 
actual versus predicted plot (See Figure 2e) indicates a much better prediction performance compared with models for 
the prediction of the incubation time for both IR and Raman (Figure 1(f), Figure 2(c)). The permutation test (6LV) 
showed that the RMSECV found (0.025 h) was considerably more significant (p<0.00001) than the error calculated for 
the regression against incubation time. The fact that the IR variables could clearly predict the intensity of a DOX band 
in the Raman spectra indicated that there was a linear relationship between the infrared variables and the concentration 
of DOX in the nucleus of the cell. Two explanations are proposed: (i) The IR spectra contained drug bands and the 
concentration of DOX was above the limit of detection of technique. (ii) The drug provoked immediate changes in the 
biochemical constituents of the cells, which were directly proportional to the presence of DOX and which caused 
significant changes to the IR spectra.  
Once again, the selectivity ratio and the component loading values were used to study the bands responsible for the 
prediction (See Figure 2d). Strong positive contributions (yellow colours) with high selectivity ratio values were found 
at wavenumbers related to lipids such as 1400, 1740, 2850 and 2929 cm-1. A strong positive contribution for the amide 
II (~1545 cm-1) and a negative contribution for the amide I (~1650 cm-1) were also observed, which may indicate changes 
in the conformation of proteins. The latter band could be also associated with a decrease of the RNA and DNA bands 
when increasing the amount of DOX in the nucleus. On the other hand, specific markers of DOX,[34] such as the bands 
found at 1283 cm-1 (δO-H …O) and 990cm-1 (δC-OH) were not evident. These bands are the most intense in the IR 
spectrum of DOX [29], and are in a region where other cell components do not show high absorbances. The lack of 
spectral markers associated to these bands evidences a negligible contribution of DOX bands to the IR spectra, probably 
because of the low concentration of DOX within the cell (i.e. below the limit of detection of IR). The absence of spectral 
markers associated with these bands evidences a negligible contribution of DOX bands to the IR spectra, probably 
because of the low concentration of DOX within the cell (i.e. below the limit of detection of IR). The concentration of 
a human genome within a cell is also relatively low, weighting ≈ 6pg[43] from the total weight of ≈1ng[44] of a human 
cell.  In a previous study, Agudelo et al. identified changes in the DNA IR bands in transmission measurements of 
solutions of mixtures of DOX and DNA. [45] However, results of this study did not indicate that the interaction DNA-
DOX affected DNA bands in the IR spectrum. This can be caused by the low intensity of DNA bands in the IR spectrum 
of cells, especially in fixed or dried cells, [40] when using such small pathlengths such as in the microscopy measurements 
of cells. 
Hence, the analysis of variables supports the hypothesis that, rather than the drug, the IR spectroscopy detected 
changes produced by the presence of the drug, indicating that, as expected, the pre-resonant signal of DOX in Raman 
provides better sensitivity than IR in detecting the drug, which offers further information about changes in the 
biochemical composition.  
 
3.3 2D Correlation Analysis. 
Since the use of Raman data was beneficial in the analysis of IR variables in the oPLSR models, dedicated data fusion 
methods were investigated. 2D correlation analysis [46] was therefore employed to investigate the relationship between 
the IR and Raman variables. In brief, 2D correlation analysis computes a measure of the correlation for each combination 
of variables obtained from two different modalities, which are plotted in a correlation map to study the relationship 
between the information provided by the techniques across the different samples. 2D correlation provides a synchronous 
and an asynchronous spectrum. The first computes the correlation among the variables in the dataset, enabling the 
investigation of relationship of the IR and Raman intensities. The later takes into account the variable time, and can be 
used to investigate the directions of the spectral changes across time. Further information about 2D correlation analysis 
can be found here.[26,27,46] To aid the interpretation of the synchronous coefficients, a simulated dataset was created, in a 
similar way to previous studies [9,12]. In this way, one can study the expected results and then compare them with the real 
data. The simulated Raman dataset from ref [9] was used, but it was extended to simulate also IR spectra. The Raman 
spectra contained two artificial features, which represent the initial rapid uptake and binding of the drug to RNA/DNA 
in the nucleus, and a slower, secondary response to represent the subsequent cellular response (See SM3). Similar 
constructs were also added to the IR spectra following the same kinetic profile. The drug uptake was represented as a 
decrease of typical DNA bands at 1660, 1239, 1085 cm-1 and, following the results of the oPLSR, the secondary cell 
response was simulated by an increase of lipid bands at 2930, 2850, 1750 and 1399 cm-1. The 2D correlation analysis 
of the data obtained (See Figure 3a) showed two clear set of correlations between the Raman and IR bands which 
increased or decreased as a function of the incubation time. In particular, DOX Raman bands were positively correlated 
with the lipid   IR bands (Red Arrows) and were inversely correlated   with the DNA IR bands (Black Arrows).  
Figure 3(b) shows the contour plot of the synchronous correlation of the IR and Raman spectral datasets measured 
at the different incubation times. It can be seen several negative and positive correlation. A large part of them correspond 
to correlations between DOX Raman bands and sets of IR bands bands, highlighting  characteristic bands at 430-480 
and ~1200 cm-1, which  were found to be positively correlated with the IR bands related to lipids, found at ~2930, ~2850 
and ~1400 cm-1 (See red arrows). The latter can be assigned to the COO- stretching from fatty acids, but can also be 
assigned to amino acid side chains[41]. It has to be noted, however, that the characteristic ester band at 1740 cm-1 was not 
found to be positively correlated to the drug bands. Furthermore, in good agreement with the results from the oPLSR 
model, DOX bands were positively correlated with the band found at ~1540 cm-1 and negatively correlated with the 
band at ~1660 cm-1  (See black arrows). It can be also observed that the amide I band in both IR and Raman are positively 
correlated. Compared to the simulated data, the band at 1640 cm-1 showed the same negative correlation, but no 
correlation was found for the phosphate bands at 1239 and 1085 cm-1. This supports the assignment of the 1660 cm-1 to 
changes in the protein conformation. On the other hand, the lipid bands at 2930, 2850 and 1400 cm-1 showed similar 
correlation and the band at 1750 cm-1 did not show any correlation. Once again, the Raman bands were helpful in 
identifying IR spectral markers linked to the presence of the drug.  
The asynchronous correlation for the simulated and real dataset is shown in SM4. The analysis of the simulated 
data showed positive peaks between the Raman DOX bands and the FTIR lipidic bands. The real dataset showed a large 
number of positive and negative peaks. Considering the high degree of complexity of the system and the low number of 
timepoints, the interpretation of such number of peaks in an asynchronous analysis is challenging and thus, only the 
synchronous correlation was analysed.  
3.4 MCR-ALS 
The main problem on studying correlations between variables is that they do not account for possible non-linear 
effects found in the kinetic processes of drug uptake. MCR-ALS is a more sophisticated method which enables analysis 
of complex variations of components within a chemical system. It is a versatile technique which can use constraints 
based on known information about the system to improve the interpretability of the results. In a previous study, this 
method was applied to simulated spectra of DOX, successfully capturing two different process with two different 
kinetics, which simulated the drug uptake and the subsequent cellular response[9]. In this study MCR-ALS, was applied 
to the combined IR and Raman dataset to decompose the extended data matrix of the concentration and spectra matrices, 
containing concatenated IR and Raman spectra. Based on a Singular Value Decomposition, three components were 
chosen. The uptake of the drug and its kinetics were incorporated into the model by constraining the first component to 
represent the Raman spectrum of the drug measured in aqueous solution, leaving the IR spectrum to be modelled by the 
MCR-ALS. Furthermore, the concentration profile of the first component was adjusted to the kinetic profile of DOX, 
measured as the integration of the Raman bands of DOX found at 430-480 cm-1. In order to avoid possible propagation 
of experimental errors from the Raman to the IR, the concentration was fitted to a kinetic equation previously 
proposed.[12]. In summary, concentrations and Raman part of component #1 were constrained. The IR part of component 
#1, the IR and Raman spectra as well as the concentrations profiles of components #2 and #3 were also left without any 
equality constraint, to be modelled by the MCR-ALS. Furthermore, non-negativity constrains were applied for both 
concentrations and spectra.  
Results of the MCR-ALS are depicted in Figure 4. The concentration profile of the three components (See Figure 
4c) shows that component #1 (Blue) follows the kinetic pattern of the uptake of the drug, as described by the Raman 
spectra (introduced in the constraint). The other two components did not follow any defined trend over time. The Raman 
spectra of component #1 (See Figure 4a) also shows the constrained DOX standard spectrum, whereas the other 
components showed similar bands to the biological components of cells (Raman spectra of cell is indicated as a black 
dotted line). In the IR spectrum (See Figure 4b), component #2 and #3 also showed typical spectral features of cells, 
including amide and phosphate bands. It should be noted that these components show typical biochemical bands for 
both, Raman and IR, and considering the random fluctuations of their concentration profiles, they may represent changes 
of cell components not related to the time. The IR spectral features of component #1 are associated with the uptake and 
represents the changes in the IR as a result of the action of DOX in the nucleus. They include bands found at 2929, 
2850, 1740 and 1400 cm-1, which can be related to lipids. In addition, a band at 1540 cm-1, tentatively assigned to Amide 
II from proteins, can be found. The presence of this feature indicates an increase of this bands following the same kinetic 
as DOX uptake measured by the Raman signal. Compared to oPLSR and 2D correlation, similar lipidic features were 
found, although MCR-ALS also identified the 1740 cm-1 C=O band as associated with the uptake of DOX. The absence 
of this band in oPLSR and 2D correlation can be caused by negative contributions of the band at 1660 cm-1, which could 
be associated to changes in protein conformation. In contrast, negative correlations of 1660 cm-1 were not identified by 
MCR-ALS, consistent with previous studies which evidenced some limitations in reporting synchronous negative and 
positive contributions. [9].  
3.5 Evaluation of independent and joint analyis of IR and Raman data 
In this study, we explored the analysis of DOX uptake by cells using IR and Raman spectroscopy, independently, 
and in a combined, or joint fashion. As stressed in the introduction, IR and Raman provide complementary information 
about the sample because, among other reasons, in most biomolecules there is an inverse correlation found between the 
Raman scattering cross section and the infrared extinction coefficient. Raman provided clear information about the drug 
uptake using typical bands at 430-480 cm-1. The high sensitivity of Raman to detect DOX made the analysis 
straightforward, without the need of any supervised method to follow the DOX kinetics. However, the investigation of 
further changes to other biochemical composition was challenging. Raman is a well-established technique that may 
identify both drug uptake and subcellular response as it is also sensitive to changes in the biochemical composition of 
the cell. In this case, the subcellular response in Raman was limited to changes in the DNA bands. Regarding IR, the 
spectral contribution of DOX was negligible compared to that of the majority constituents such as proteins, 
carbohydrates, nucleic acids and lipids, which show characteristic spectral markers in the IR.  The results showed that 
IR bands better illustrated changes in these majority components, evidencing changes in lipid and protein bands. 
Nevertheless, the investigation of the temporal evolution of such markers was troublesome because they were only 
found using supervised, linear methods such as oPLSR. The linear model was skewed, considering the fact that the drug 
uptake is not a linear function of  incubation time. In the absence of previous analysis which confirmed the correlation 
of these bands with the incubation time (such was the case of Raman), the validity of these IR markers is questionable. 
However, the use of the Raman signal of DOX as a variable to guide the oPLSR produced much more reliable 
results. It provided a response which was linear with the biochemical changes produced by the presence of the drug and 
enabled identification of IR spectral markers. This clearly exemplifies how the hyphenation of the techniques makes 
facilitates the data-mining of information from one single technique by indirectly increasing the knowledge of the 
system. Furthermore, joint analysis of Raman and IR data using 2D correlation and MCR-ALS offered a much clear 
description of the system, showing strong correlations between DOX Raman bands and IR spectral markers associated 
with changes in biochemical constituents related to the presence of the drug. The joint analysis of the IR and Raman 
data was limited by the intrinsic constraints of the respective techniques. In the first place, the analysis was performed 
on fixed cells. The opacity of water in the mid-IR region makes the acquisition of spectra of living cells difficult. In 
Raman, this task is in theory more achievable, although special equipment is needed to maintain the cells in conditions 
similar to the ones found in an incubator. In addition, the lack of high throughput IR and Raman microscopes which can 
measure several samples containing thousands of cells automatically makes the acquisition of a representative number 
of cells for a large number of timepoints extremely time-consuming. This hampers the use of MCR-ALS to capture 
different kinetic process at different rates.[9] Finally, the differences in spatial resolution played a critical role in the 
interpretation of results. The IR spectra were averaged from the whole cell, reflecting changes in major components 
from nucleolus and cytoplasm. In contrast, Raman spectra were obtained from the nucleus and thus, the correlation 
between the DOX signals and IR markers of lipids should be understood as an increase of lipids in the whole cell as the 
concentration of DOX builds up in the nucleus. Recent technical advances in IR and Raman spectroscopy are aimed to 
overcome these challenges, for example increasing the spatial resolution of IR images by photothermal spectroscopy of 
live cells, simultaneously collected with Raman data [47],  and development of rapid microfluidic cell-sorting systems to 
trap cells while maintaining suitable environmental conditions for cell survival[48]. The combined use of these new 
techniques with data fusion methodologies could provide a very valuable high content, high throughput tool for 
comprehensive analysis of, for example, drug uptake and cellular responses in pre-clinical drug development workflows. 
As stressed in the introduction, the combination of both techniques increases considerably the complexity of the data to 
analyse and entails challenges in the measurement process (e.g. compatibility of substrates and spatial resolution). Thus, 
it has to be noted that the multimodal approach will not be the most suitable in all scenarios. In the case of this study, if 
the goal had been limited to the kinetic study of the drug uptake, localisation, and its interaction with the DNA, Raman 
alone would have provided a satisfactory analysis without the need for more complex analysis. However, if the goal is 
to obtain an extended picture, results demonstrated that the IR could provide information about the macromolecular 
changes associated with the drug uptake. 
4. Conclusions 
The study of DOX uptake and cellular response combining IR and Raman offered more valuable information than 
the independent analysis of data from the two techniques. Raman DOX bands found at 1212 and 430-480 cm-1 provided 
good insight into the drug uptake, due to the strong polarisability and conjugated bonds of DOX. Thus, Raman analysis 
provides kinetic information about the drug uptake as well as hints about DNA intercalation  by itself without the need 
of complex mutivariate processing. In contrast, further information about the biochemical response of the cell was not 
easily elucidated. In the case of IR, spectral changes related to the incubation time were not found unless supervised 
analysis was employed.  
 In general, most of these band markers including the 2830, 2940, 1740 and 1400 cm-1 indicate an increasing on 
the relative concentration of lipids in cells correlated with an increase of the drug within the nucleus. The investigation 
of the changes in bands found at 1660 cm-1 (negatively correlated with the drug) and 1540 cm-1 (positively correlated 
with the drug) is more challenging. It can be tentatively assigned to changes in the ratio amide I to amide II provoked 
by changes in the conformation of proteins. Pleated sheets have been proposed as apoptosis marker in membrane of 
cells[49]. On the other hand, changes in the band found at 1660 cm-1 can also be caused by alterations in the conformation 
on the DNA, although typical phosphate DNA bands found at 1075 cm-1  and 1240 cm-1 did not show major changes. 
Thus, the interpretation of the bands found at 1540 and 1660 cm-1  remain inconclusive and further studies with a large 
number of timepoints should be carried out to study complex cell responses using MCR-ALS. In summary, the fusion 
of vibrational data improved the whole analysis in two main respects. Firstly, Raman assisted in extracting information 
from the IR spectra by providing knowledge about the drug uptake. Furthermore, the analysis of joint data by 2D 
correlation and MCR-ALS provided a comprehensive picture of the uptake process, combining the sensitivity of Raman 
for the drug detection and the information about the major biochemical components found in the IR bands. Although 
the multimodal vibrational analysis of drug uptake still suffers from limitations regarding the low spatial resolution of 
conventional IR microscopy as well as the general throughput of current commercial microscopes, the study 
demonstrates the potential of joint analysis approaches, in anticipation of emerging technological developments. 
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Figure 1. Raman study of DOX uptake. (a) Average Raman spectra of cells inoculated at different timepoints. (b) 
Temporal evolution of the integrated the 420-470 cm-1 band. Shading indicates the standard deviation. (c) Spectral 
Loading of PC3 and Raman spectra of a DOX aqueous solution standard. (d) PC3 Average Score values over time. (e) 
Scatter plot indicating the average Raman spectra. The colour scale indicates the component loading of the oPLSR and 
the size of the points is proportional to the selectivity ratio. (f) Actual time versus the time predicted by the cross 
validation of the oPLSR. The dashed line depicts the idealised 1:1 correlation. 
  
 
Figure 2. Infrared study of DOX uptake by cells. (a) Average infrared spectra of cells inoculated at different timepoints. 
(b) Analysis of variables of the oPLSR which predicted the incubation time. The scatter plot indicates the average 
infrared spectra, the colour scale indicates the component loading of the oPLSR and the size of the points is proportional 
to the selectivity ratio. (c) Actual time versus the time predicted by the cross validation of the oPLSR model which 
predicted the incubation time. (d) Analysis of variables of the oPLSR model which predicted the 430-482 cm-1 Raman 
band. The scatter plot indicates the average infrared spectra, the colour scale indicates the component loading of the 
oPLSR and the size of the points is proportional to the selectivity ratio. The dashed line depicts the idealised 1:1 




Figure 3. Synchronous coefficients obtained from the 2D correlational joint analysis of Raman and IR data. (a) 
Simulated Dataset. (b) Experimental Dataset. 
  
 
Figure 4. MCR-ALS results for the joint analysis of IR and Raman datasets. (a) Pure Raman spectra of the three 
components. Black dotted line represents the Raman spectra of a cell (Shortest incubation time). (b) Pure Infrared 
spectra of the three components considered. (c)Evolution of the concentration profiles over time of the three components 
considered.   
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SM1: Score and loading values corresponding to Principal Components #1 and #2 obtained from the PCA of the 



































SM2: Score and loading values corresponding to Principal Components #1, #2 and #3 obtained from the PCA of the IR 






































SM3: Simulation of the IR and Raman spectrum. Artificial construct added to the spectra for IR (a) and Raman (b). (c) 



















SM.4 Asynchronous analysis for simulated and real data.  
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